To read more on this topic click here.
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
Author: Pippa Prendergast-CoatesPublished: 6 August 2020
Prep: Cook: Serves:
A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition.
As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s.
The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be conducted to find the optimal use.
For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.
US hospital initiative improves on-time administration of Parkinson’s medication
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Share this story
Parkinson’s in the news: June
We round up the top Parkinson’s news stories from around the globeREAD MORE
Parkinson’s prevalence expected to increase by 18% in next seven years
Aging UK population could see increase in Parkinson’s over timeREAD MORE
Tickets on sale for ‘Insight into Parkinson’s’ summit 2019
Tickets for the online event are now on saleREAD MORE